June 4 - 5, 2025
Javits Convention Center

September 2023 National News Update: Unveiling Key Cannabis Bills in Congress 

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter (now X) to get the most recent edition when it’s published.

 

 

As September 2023 comes to a close, the U.S. Congress once again jumps into the ongoing narrative of cannabis reform. From bipartisan efforts to advance banking bills to moves to federally legalize cannabis, the House of Representatives is at the forefront of these transformative discussions. Join us as we unpack the latest developments in cannabis legislation and defining moments of September. 

 

SAFER Banking Act clears committee

 

 

 

This story was edited on Sept. 27th, 2023 to include an update on the SAFER Banking Act.

In a milestone that has sent waves of excitement throughout the cannabis industry, the bipartisan Secure and Fair Enforcement Regulation (SAFER) Banking Act has made its way through committee.

 

On Sept. 27th, the Senate Banking Committee voted to approve the SAFER Banking Act, advancing this legislation to the Senate floor. While additional amendments are pending, the 14-9 vote of approval from the committee is breathing new life into a bill that has stalled for years.

 

U.S. Senators Jacky Rosen (D-NV) and Steve Daines (R-MT) introduced the SAFER Banking Act on September 20th, just ahead of a pivotal committee vote. The bill, formerly known as the SAFE Banking Act, aims to ensure that legal cannabis businesses can reliably access banking and insurance services, ultimately fostering safe communities and broadening economic opportunities.

 

Currently, federal regulations strictly control financial services for cannabis companies, resulting in a lack of access to crucial banking for many independent operators. Consequently, numerous businesses operate predominantly with cash, leaving operators, customers, and staff at increased risk of criminal activity. 

 

“This legislation will help make our communities and small businesses safer by giving legal cannabis businesses access to traditional financial institutions, including bank accounts and small business loans,” the senators said. “It also prevents federal bank regulators from ordering a bank or credit union to close an account based on reputational risk.”

 

In a separate statement, Senate Majority Leader Chuck Schumer (D-NY) said that he is committing to attaching legislation incentivizing state-level cannabis expungements and restoring gun rights for medical cannabis patients. Specifically, he said he would move to add the Harnessing Opportunities by Pursuing Expungement (HOPE) Act and Gun Rights and Marijuana (GRAM) Act to the final legislation.


House Democrats introduce bill to federally legalize cannabis

 

 

 

Representative Jerrold Nadler (D-NY) has rekindled efforts to federally legalize and regulate cannabis. On September 20th, Nadler reintroduced the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, a comprehensive bill that not only seeks to dismantle the federal prohibition of cannabis but also includes provisions for taxing and expunging prior convictions related to the plant. The bill has 33 co-sponsors, all of whom are Democrats. 

 

This marks the third time the MORE Act has made its way to the House, with prior versions passing. However, its reintroduction under Republican control raises questions about its potential progression.

If passed, the MORE Act would deschedule cannabis, removing it from federal drug restrictions while allowing states to retain regulatory authority over its legality. However, it would not require states to legalize cannabis. It also proposes a federal tax structure for cannabis sales, starting at 5% for the first two years and rising to 8% percent by the fifth year. A portion of the tax revenue would be aimed at addressing the impact of federal prohibition, particularly on communities of color. 

 

Congressional committee approves CURE Act, removing cannabis as a barrier to federal employment

 

 

 

The House Oversight and Accountability Committee officially passed the Cannabis Users’ Restoration of Eligibility (CURE) Act on Sept. 20th with a 30-14 vote. Sponsored by Reps. Jamie Raskin (D-MD), Nancy Mace (R-SC), and Earl Blumenauer (D-OR), the bill aims to eliminate barriers to federal employment and security clearance based on past cannabis consumption. The CURE Act would also allow those previously denied a security clearance or a federal job opportunity based on cannabis use a chance to have the denial reviewed. Supporters of the bill included 30 House members, 10 of which are Republican. 

 

However, while initially designed to cover both past and current cannabis consumers, members adopted amendments from James Corner (R-KY) to refine specific provisions. The amended bill narrows the protections to apply exclusively to prior cannabis use. This means federal workers and security clearances could still face penalties for active consumption. Additionally, the amendment addresses language concerning agencies’ obligation to review denials based solely on cannabis use for security clearances or employment. 

 

“Federal hiring policies are confusing enough, and this is one area where we can work in a bipartisan way to clarify and codify what is largely an existing practice,” Chairman Corner said during the full committee meeting on Sept. 20th.

 

Join the conversation with CWCBExpo


The bills introduced this month are poised to shape the future of cannabis policy in the United States. Those eager to stay at the forefront of this evolving landscape must look no further than CWCBExpo. Our comprehensive coverage and
annual B2B conference offer accurate updates and the opportunity to connect and network with experienced industry professionals. With CWCBExpo, you’re not just staying informed but becoming part of the conversation. 

September 2023 Regional News Update: Northeast Faces Regulatory Shifts and Licensing Milestones 

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter (now X) to get the most recent edition when it’s published.

September 2023 brought major changes to the Northeast cannabis scene, as some markets expanded and others faced significant setbacks. Join us as we unravel these pivotal moments and explore the ever-changing narrative of the East Coast cannabis industry. 

NJ set to expand edibles market with newly-approved rules 


In New Jersey, the Cannabis Regulatory Commission (CRC) made strides in expanding the range of edible products available in the state’s cannabis market. 

In a landmark decision during a September 8th meeting, proposed rules were passed to relax restrictions on infused products and open the doors to a broader array of options for consumers. While the state had previously limited the sales of cannabis edibles to non-food-like products such as lozenges and soft chews, dispensaries can now begin stocking infused chocolates, baked goods, butter, jams, and beverages. The new rules require products to be made uniformly, staff to receive food safety training, and packages to have nutrition labels and expiration dates.

The new rules were approved unanimously for medical and recreational dispensaries. It now undergoes a 60-day public commenting period. 

NJ delivery, wholesale, distribution companies can soon apply for licenses

Starting Sept. 27th, the CRC will begin accepting applications for wholesalers, distributors, and delivery services. While medical facilities have been permitted to deliver to patients since 2020, adult-use dispensaries have yet to allow this service. 

  • A Class 6 Cannabis Delivery license allows companies to deliver cannabis products to eligible adult-use customers on a dispensary’s behalf.

  • A Class 3 Cannabis Wholesale license allows the holder to store, buy, and sell bulk cannabis and cannabis products.

  • A Class 4 Cannabis Distribution license allows the holder to transport bulk cannabis and cannabis products between cannabis cultivators, manufacturers, or retailers within New Jersey.

“The launch of these new cannabis business license classes represents a significant step in the continued growth and diversification of New Jersey’s cannabis industry,” said Commission Chairwoman Dianna Houenou in a press release.

Despite around 70% of municipalities opting out of allowing legal cannabis businesses in New Jersey, the addition of delivery in the state means that these residents in those towns can still easily access cannabis. Cannabis can be delivered anywhere in the state; state law does not allow municipalities to restrict delivery services from delivering products to residents of their municipalities.

At first, the NJCRC will exclusively accept social equity applications from business owners with prior convictions for cannabis offenses. Diversely-owned enterprises, encompassing minority-owned, woman-owned, or disabled veteran-owned businesses, will have the opportunity to apply starting December 27th. Other interested parties will be able to submit their applications beginning March 27th, 2024. 

CAURD lawsuit continues to drag on in New York

Last month, Judge Kevin Bryant ordered the NYS Cannabis Control Board (CCB) and Office of Cannabis Management (OCM) to halt awarding or further processing any more conditional adult use retail dispensary (CAURD) licenses after a lawsuit brought by four New York veterans. They argued that the CAURD program, designed for entrepreneurs affected by cannabis enforcement, is unconstitutional.

The order continues to stall the rollout period of adult-use cannabis dispensaries, with hundreds of license holders unable to open their doors. 

While these businesses will have the opportunity to re-apply for general licensing in October 2023, the program expansion opens the doors for the state’s medical cannabis operators and large MSOs to apply. As regulators keep their doors open for retail or microbusiness applications until Dec. 23rd, 2023, concerns linger over how this might affect small businesses like CAURD applicants. More decisions are expected from the court throughout the remainder of 2023.

PA Senate Moves to Increase Medical Cannabis Access  

The Pennsylvania State Senate has passed Senate Bill 773, a measure that could reshape the state’s medical cannabis landscape. The bill proposes that all licensed cannabis grower-processors in the state be granted dispensary permits, thereby enabling them to serve medical cannabis patients directly. It received a 44-3 bipartisan vote. 

This marks a departure from the current framework established by PA’s Medical Marijuana Act of 2016, which restricts the number of grower/processor license holders with dispensary privileges to just five out of the 25 total. The remaining license holders are currently obligated to distribute their products through retail dispensaries, acting as intermediaries. 

The system has received criticism for fostering a near-monopoly, prompting lawmakers to advocate for such a corrective measure. The bill, sponsored by Sen. Chris Gebhard (R-48), will head to the House next. 

Stay in the loop with updates you can trust

As we wrap up this month’s update, it’s evident that the Northeast cannabis industry is brimming with potential and challenges alike. Staying well-informed amidst these shifts is paramount, and trustworthy sources are essential. You can always rely on CWCBExpo’s monthly updates to serve you relevant industry news.

Loading...